Jin Yoo, MD
Surgery · Durham, NCNPI 1811162142
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Covidien LP at 27.5% of the total. Reporting peaked in 2019 at $63,083 and has fallen 74.3% since, to $16,183 in 2025. Among surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 542 payments — averaging $329.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$49K
- Medtronic$36K
- W. L. Gore & Associates, Inc.$30K
- Olympus America Inc.$21K
- Conmed Corporation$9K
- Endolumik, Inc.$7K
- plus $27K from 28 others
Across 40 payments — averaging $3737.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Covidien LP$97K
- Medtronic$52K
What the payments were for
- Consulting fees$53,73730%
- Speaking & faculty fees$76,71443%
- Travel & lodging$23,00613%
- Food & beverage$24,24814%
- Education$8700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 110 | $49,157 |
| Medtronic(2 entities) | 149 | $35,562 |
| W. L. Gore & Associates, Inc. | 68 | $30,065 |
| Olympus America Inc. | 13 | $21,228 |
| Conmed Corporation | 7 | $8,735 |
| Endolumik, Inc. | 4 | $6,815 |
| Intuitive Surgical | 58 | $5,692 |
| TELA Bio, Inc. | 39 | $3,942 |
| Teleflex LLC | 9 | $3,025 |
| Applied Medical Resources Corporation | 6 | $2,880 |
| Davol Inc. | 3 | $2,549 |
| AbbVie | 13 | $2,124 |
| Activ Surgical, Inc. | 11 | $1,701 |
| Johnson & Johnson | 14 | $998 |
| Olympus Corporation Of The Americas | 1 | $870 |
| Innocoll Pharmaceuticals Limited | 6 | $754 |
| Gyrus ACMI, Inc. | 1 | $492 |
| RTI Surgical, Inc | 4 | $376 |
| Heron Therapeutics, Inc. | 2 | $257 |
| Stryker | 3 | $221 |
| Integra Lifesciences Corporation | 4 | $191 |
| Baxter Healthcare | 2 | $183 |
| Standard Bariatrics, Inc. | 1 | $179 |
| Cook Medical LLC | 1 | $151 |
| Lilly USA, LLC | 1 | $122 |
| Abbott | 4 | $72 |
| Tricoast Surgical Solutions LLC | 1 | $58 |
| KARL Storz Endoscopy-america | 1 | $52 |
| Levita Magnetics International Corp | 1 | $38 |
| Bolder Surgical LLC | 1 | $30 |
| Arthrex | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProGrip$23,217
- SYNECOR Biomaterial$20,048
- Sonicision$10,838
- AIRSEAL$8,642
- Endolumik Gastric Calibration Tube$6,815
- GORE SYNECOR Biomaterial$6,204
- Dextile$5,965
- GORE BIO-A Tissue Reinforcement$5,720
- GORE ENFORM Preperitoneal Biomaterial$5,720
- TRANSORB$4,525
- Da Vinci Surgical System$4,159
- LigaSure$3,392
- ProTack$3,000
- GelPOINT V-Path$2,864
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$2,715
- ALLODERM$1,633
- Spacemaker$1,500
- ActivSight$1,449
- Signia$1,382
- BIO-A Tissue Reinforcement$1,207
How this compares
$178,576 in reported general payments places this provider in the 95th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Misoprostol | 15 | $1,583 |
| Pantoprazole Sodium | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other surgery in Durham
- Dana PortenierDurham$702K
- Phillip ShadduckDurham$222K
- Christopher MantyhDurham$132K
- Sabino ZaniDurham$113K
- Alfredo Guerron CruzDurham$55K
- Jacob SchroderDurham$47K
- Christopher MyersDurham$36K
- Dan BlazerDurham$34K
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.